Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Aardvark Therapeutics Sector: Oral gut-restricted bitter taste receptor agonists for hunger suppression HQ: San Diego, CA Year Founded: 2017 Origin Story: Aardvark Therapeutics was founded around a mechanistically distinct hypothesis: rather than suppressing appetite like GLP-1 drugs, the companys lead compound activates bitter taste receptors (TAS2Rs) confined to the gastrointestinal tract to trigger local release of satiety hormones, targeting hunger itself without systemic drug exposure
Current Evidence on Peptides for Weight Management Strong clinical evidence exists only for licensed GLP-1 receptor agonists (semaglutide and liraglutide)
By understanding each component and using the right resources, youll be empowered to achieve and maintain your health goals for years to come
Better injections and better pills
Where insurance walls feel too high, access feels too small, and the comment section on the socials cant seem to move past the idea that obesity is all about willpower instead of biology
US$ 28.63
US$ 23.27
US$ 24.93
